MiMedx Group Inc
NASDAQ:MDXG
MiMedx Group Inc
NASDAQ:MDXG
Price:
7.92
USD
0.38%
Market Closed
Market Cap:
1.2B
USD
Balance Sheet
Balance Sheet Decomposition
MiMedx Group Inc
MiMedx Group Inc
| Current Assets | 172.1m |
| Cash & Short-Term Investments | 88.8m |
| Receivables | 54m |
| Other Current Assets | 29.3m |
| Non-Current Assets | 71.8m |
| PP&E | 9.3m |
| Intangibles | 30.6m |
| Other Non-Current Assets | 31.8m |
Balance Sheet
MiMedx Group Inc
MiMedx Group Inc
Currency: USD
Millions
Annual
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
47
|
29
|
34
|
28
|
45
|
69
|
96
|
87
|
66
|
82
|
|
| Cash Equivalents |
47
|
29
|
34
|
28
|
45
|
69
|
96
|
87
|
66
|
82
|
|
| Short-Term Investments |
6
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
27
|
54
|
67
|
1
|
1
|
32
|
46
|
41
|
44
|
54
|
|
| Accounts Receivables |
27
|
54
|
67
|
0
|
0
|
32
|
35
|
40
|
43
|
54
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
10
|
1
|
1
|
0
|
|
| Inventory |
5
|
8
|
18
|
10
|
16
|
9
|
10
|
11
|
13
|
21
|
|
| Other Current Assets |
2
|
4
|
7
|
11
|
13
|
13
|
9
|
9
|
11
|
7
|
|
| Total Current Assets |
86
|
96
|
127
|
49
|
74
|
123
|
161
|
149
|
134
|
164
|
|
| PP&E Net |
5
|
10
|
14
|
14
|
17
|
16
|
15
|
14
|
11
|
9
|
|
| PP&E Gross |
5
|
10
|
14
|
14
|
17
|
16
|
15
|
14
|
11
|
9
|
|
| Accumulated Depreciation |
4
|
5
|
9
|
13
|
19
|
24
|
30
|
33
|
36
|
20
|
|
| Intangible Assets |
11
|
11
|
23
|
10
|
10
|
8
|
6
|
5
|
6
|
5
|
|
| Goodwill |
4
|
4
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
19
|
|
| Long-Term Investments |
3
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
15
|
10
|
28
|
2
|
0
|
0
|
0
|
0
|
41
|
|
| Other Assets |
4
|
4
|
20
|
20
|
20
|
20
|
20
|
20
|
20
|
19
|
|
| Total Assets |
109
N/A
|
136
+24%
|
193
+42%
|
121
-37%
|
123
+1%
|
167
+36%
|
202
+21%
|
188
-7%
|
171
-9%
|
239
+39%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
4
|
7
|
11
|
9
|
15
|
9
|
9
|
7
|
9
|
9
|
|
| Accrued Liabilities |
14
|
20
|
23
|
37
|
55
|
55
|
50
|
35
|
34
|
33
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
0
|
0
|
0
|
1
|
|
| Other Current Liabilities |
1
|
1
|
16
|
1
|
2
|
0
|
0
|
0
|
0
|
3
|
|
| Total Current Liabilities |
18
|
27
|
51
|
46
|
72
|
67
|
59
|
42
|
44
|
46
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
62
|
48
|
48
|
49
|
48
|
|
| Other Liabilities |
2
|
1
|
10
|
2
|
2
|
4
|
4
|
5
|
5
|
2
|
|
| Total Liabilities |
20
N/A
|
28
+40%
|
60
+116%
|
48
-21%
|
73
+54%
|
133
+81%
|
111
-17%
|
95
-14%
|
97
+2%
|
96
-1%
|
|
| Equity | |||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
92
|
93
|
93
|
0
|
|
| Retained Earnings |
68
|
38
|
26
|
47
|
77
|
102
|
151
|
162
|
192
|
134
|
|
| Additional Paid In Capital |
162
|
163
|
161
|
165
|
165
|
147
|
159
|
166
|
174
|
276
|
|
| Treasury Stock |
6
|
17
|
2
|
44
|
39
|
11
|
7
|
4
|
0
|
0
|
|
| Total Equity |
89
N/A
|
108
+21%
|
133
+23%
|
74
-45%
|
50
-33%
|
34
-31%
|
91
+166%
|
93
+1%
|
75
-20%
|
143
+92%
|
|
| Total Liabilities & Equity |
109
N/A
|
136
+24%
|
193
+42%
|
121
-37%
|
123
+1%
|
167
+36%
|
202
+21%
|
188
-7%
|
171
-9%
|
239
+39%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
108
|
107
|
110
|
109
|
109
|
111
|
111
|
112
|
114
|
146
|
|
| Preferred Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
